Morton Grove, IL, January 21, 2014 – Regis Technologies, Inc., today reported that it successfully passed a recent U.S. Food & Drug Administration (FDA) audit with no Form 483 observations. Form 483 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback